232 related articles for article (PubMed ID: 23184818)
1. Functional silica nanoparticles for redox-triggered drug/ssDNA co-delivery.
Ma X; Nguyen KT; Borah P; Ang CY; Zhao Y
Adv Healthc Mater; 2012 Nov; 1(6):690-7. PubMed ID: 23184818
[TBL] [Abstract][Full Text] [Related]
2. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
3. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity.
Luo Z; Cai K; Hu Y; Zhang B; Xu D
Adv Healthc Mater; 2012 May; 1(3):321-5. PubMed ID: 23184747
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
7. Drug encapsulation and release by mesoporous silica nanoparticles: the effect of surface functional groups.
Tan SY; Ang CY; Li P; Yap QM; Zhao Y
Chemistry; 2014 Sep; 20(36):11276-82. PubMed ID: 25044108
[TBL] [Abstract][Full Text] [Related]
8. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.
Han N; Zhao Q; Wan L; Wang Y; Gao Y; Wang P; Wang Z; Zhang J; Jiang T; Wang S
ACS Appl Mater Interfaces; 2015 Feb; 7(5):3342-51. PubMed ID: 25584634
[TBL] [Abstract][Full Text] [Related]
9. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.
Gao Y; Chen Y; Ji X; He X; Yin Q; Zhang Z; Shi J; Li Y
ACS Nano; 2011 Dec; 5(12):9788-98. PubMed ID: 22070571
[TBL] [Abstract][Full Text] [Related]
10. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
[TBL] [Abstract][Full Text] [Related]
11. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C
Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766
[TBL] [Abstract][Full Text] [Related]
13. pH-Tunable calcium phosphate covered mesoporous silica nanocontainers for intracellular controlled release of guest drugs.
Rim HP; Min KH; Lee HJ; Jeong SY; Lee SC
Angew Chem Int Ed Engl; 2011 Sep; 50(38):8853-7. PubMed ID: 21826770
[No Abstract] [Full Text] [Related]
14. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy.
Xu Z; Liu S; Kang Y; Wang M
Nanoscale; 2015 Mar; 7(13):5859-68. PubMed ID: 25757484
[TBL] [Abstract][Full Text] [Related]
15. Dendrimerlike mesoporous silica nanoparticles as pH-responsive nanocontainers for targeted drug delivery and bioimaging.
Dai L; Zhang Q; Li J; Shen X; Mu C; Cai K
ACS Appl Mater Interfaces; 2015 Apr; 7(13):7357-72. PubMed ID: 25765172
[TBL] [Abstract][Full Text] [Related]
16. Hybrid organic nanotubes with dual functionalities localized on cylindrical nanochannels control the release of doxorubicin.
Ding W; Kameta N; Minamikawa H; Wada M; Shimizu T; Masuda M
Adv Healthc Mater; 2012 Nov; 1(6):699-706. PubMed ID: 23184820
[TBL] [Abstract][Full Text] [Related]
17. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.
Knežević NŽ; Lin VS
Nanoscale; 2013 Feb; 5(4):1544-51. PubMed ID: 23322330
[TBL] [Abstract][Full Text] [Related]
18. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles.
Song B; Wu C; Chang J
Acta Biomater; 2012 May; 8(5):1901-7. PubMed ID: 22326789
[TBL] [Abstract][Full Text] [Related]
19. Bioresponsive mesoporous silica nanoparticles for triggered drug release.
Singh N; Karambelkar A; Gu L; Lin K; Miller JS; Chen CS; Sailor MJ; Bhatia SN
J Am Chem Soc; 2011 Dec; 133(49):19582-5. PubMed ID: 21981330
[TBL] [Abstract][Full Text] [Related]
20. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]